News
To Test or Not to Test: Perspectives on Guidelines Opposing Routine Testing Under Certain Circumstances
The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group …
FDA Approves First Generic Enoxaparin Sodium Injection
The National Blood Clot Alliance (NBCA) is alerting its membership that the Food and Drug …
Interview with Dr. Richard Friedman of Charleston Orthopedic Associates
What factors increase my chances of getting a blood clot after knee or hip replacement surgery? …
Top Tips- Orthopedic Surgery
Top Tips- Orthopedic Surgery Tell your orthopedic surgeon if you ever had a clot, or if anyone …
Next Generation Anticoagulant Pradaxa® (dabigatran etexilate) Approved
Pradaxa (Dabigatran) manufactured by Boehringer Ingelheim is the first new generation …
Stop The Clot®: What Every Healthcare Professional Should Know
Online Curriculum for Nurses, Nurse Practitioners, Physician Assistants, and Pharmacists …
Coumadin Recall
Pills May Have Higher Than Expected Potency On May 2, 2011, the US Food and Drug Administration …
NEW Survey SHOWS Gaps in DVT/PE Prophylaxis Among Hospitalized Patients
Data Demonstrate Patient Awareness is Low, Despite Increased Risks Tarrytown, NY — May …
NEW Survey SHOWS ANTICOAGULANT TREATMENT BARRIERS IMPACT DVT/PE PROPHYLAXIS DECISIONS AMONG THA/TKA SURGEONS
DVT/PE Awareness Among At-Risk THA/TKA Patients is Low Tarrytown, NY – May 16, 2011 – …
NEW SURVEY SHOWS DVT/PE AWARENESS AMONG PATIENTS WITH CANCER IS LOW
Oncology Outpatients Report DVT/PE Prophylaxis Infrequently, Compared to Inpatient Survey …
